Skip to content

The effectiveness of vitamin C and thiamine administration method in the improvement and prognosis of shock patients 1 month to 15 years

Investigating the vitamin C and thiamine administration method with the usual method in the improvement and prognosis of shock patients 1 month to 15 years

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200825048515N61
Enrollment
270
Registered
2022-10-14
Start date
2022-09-22
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shock. Shock, unspecified

Interventions

Intervention 1: First intervention group: For patients in this group, vitamin C medicine will be prescribed at a dose of 30 mg/kg every 6 hours up to a maximum of 1500 mg/dose for 4 days or until admi

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Months to 15 Years

Inclusion criteria

Inclusion criteria: Children from 1 month to 15 years Suffering from shock (other than obstructive shock) Need vasopressors to maintain at least 5% of blood pressure percentile for age Parents' consent to participate in the study

Exclusion criteria

Exclusion criteria: Having active gastrointestinal bleeding

Design outcomes

Primary

MeasureTime frame
The amount of Vasopressor requirement. Timepoint: During the intervention. Method of measurement: Number of vasopressor injections.;Ventilator requirement. Timepoint: During the intervention. Method of measurement: PaCo2<50% and pH<7.3.

Secondary

MeasureTime frame
Blood Creatinine. Timepoint: In the first four days of hospitalization. Method of measurement: Blood test.;C-reactive protein (CRP). Timepoint: In the first four days of hospitalization. Method of measurement: Blood test.;White blood cell. Timepoint: In the first four days of hospitalization. Method of measurement: Blood test.;Lactate. Timepoint: In the first four days of hospitalization. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Zibanejad

Esfahan University of Medical Sciences

zibanejadn@gmail.com+98 31 3386 6266

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026